Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

EYEN

Eyenovia Inc

May 17 • 04:00PM ET

0.7499

Dollar change -0.0710
Percentage change -8.65	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO IWC VTWG BTEC URTY VTHR

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.76	Insider Own	16.37%	Shs Outstand	45.55M	Perf Week	-2.77%
Market Cap	40.40M	Forward P/E	-	EPS next Y	-0.89	Insider Trans	1.91%	Shs Float	45.05M	Perf Month	41.25%
Income	-32.44M	PEG	-	EPS next Q	-0.21	Inst Own	14.67%	Short Float	13.69%	Perf Quarter	-55.89%
Sales	0.01M	P/S	4039.71	EPS this Y	-32.58%	Inst Trans	-28.80%	Short Ratio	4.21	Perf Half Y	-44.45%
Book/sh	0.04	P/B	19.55	EPS next Y	-1.76%	ROA	-116.94%	Short Interest	6.17M	Perf Year	-78.99%
Cash/sh	0.15	P/C	5.06	EPS next 5Y	-	ROE	-368.02%	52W Range	0.50 - 3.64	Perf YTD	-63.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	18.26%	ROI	-333.88%	52W High	-79.40%	Beta	1.73
Dividend TTM	-	Quick Ratio	0.61	Sales past 5Y	100.00%	Gross Margin	-13651.59%	52W Low	49.68%	ATR (14)	0.13
Dividend Ex-Date	-	Current Ratio	0.83	EPS Y/Y TTM	-1.25%	Oper. Margin	-321348.91%	RSI (14)	45.90	Volatility	14.12% 17.15%
Employees	57	Debt/Eq	9.15	Sales Y/Y TTM	-99.99%	Profit Margin	-369519.72%	Recom	1.00	Target Price	8.25
Option/Short	Yes / Yes	LT Debt/Eq	4.34	EPS Q/Q	-52.80%	Payout	-	Rel Volume	0.69	Prev Close	0.82
Sales Surprise	-99.30%	EPS Surprise	-2.22%	Sales Q/Q	-	Earnings	May 15 AMC	Avg Volume	1.47M	Price	0.75
SMA20	-3.43%	SMA50	-20.53%	SMA200	-50.00%	Trades		Volume	1,011,267	Change	-8.65%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-01-21	Initiated	Northland Capital	Outperform	$10
Feb-03-20	Downgrade	Oppenheimer	Outperform → Perform

May-16-24 03:07AM	Eyenovia Inc (EYEN) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com) -22.56%
May-15-24 08:55PM	EYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +28.28%
04:01PM	Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol (GlobeNewswire)
May-14-24 07:00AM	Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th (GlobeNewswire)
May-10-24 06:31AM	Formosa and Tabuk sign deal for FDA-approved ophthalmic suspension (Pharmaceutical Technology)
07:00AM	Loading…
Apr-25-24 07:00AM	Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi and Clobetasol Propionate Ophthalmic Suspension (GlobeNewswire) +21.90%
Apr-09-24 09:29AM	Eyenovia (EYEN) Down 18% on Disappointing Corporate Update (Zacks) -15.73%
Apr-08-24 07:00AM	Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities (GlobeNewswire) -17.99%
Apr-03-24 07:00AM	Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings (GlobeNewswire) -6.63%
Mar-27-24 11:28AM	NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:57AM	Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-19-24 08:50AM	Eyenovia, Inc. (NASDAQ:EYEN) Q4 2023 Earnings Call Transcript (Insider Monkey) -23.20%
06:41AM	Q4 2023 Eyenovia Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-18-24 08:53PM	EYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:20PM	Eyenovia, Inc. (EYEN) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-13-24 07:00AM	NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals (GlobeNewswire)
Mar-11-24 07:00AM	Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th (GlobeNewswire)
Mar-05-24 12:59PM	Beyond Cataract Surgery: Analyst Highlights Broader Market Potential For Eyenovia/Formosa's Steroid For Post-Eye Surgery Pain, Inflammation (Benzinga) -22.81%
08:00AM	Eyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular Surgery (GlobeNewswire)
Mar-04-24 06:21PM	UPDATE 2-US FDA approves Eyenovia's eye drug, Formosa Pharma says (Reuters)
06:06PM	US FDA approves Eyenovia's eye drug, Formosa Pharma says (Reuters)
Feb-13-24 07:00AM	Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility (GlobeNewswire) -5.76%
Jan-26-24 09:22AM	Formosa, fresh from Eyenovia deal, sells Brazilian rights to near-approval eye drug (FierceBiotech.com)
Jan-16-24 07:00AM	Eyenovia Re-Acquires Development and Commercialization Rights to MicroPine in the U.S. and Canada (GlobeNewswire) -7.51%
Dec-15-23 08:17AM	7 Promising Penny Stocks With the Potential to Defy Expectations (InvestorPlace)
Nov-14-23 10:38AM	Eyenovia, Inc. (NASDAQ:EYEN) Q3 2023 Earnings Call Transcript (Insider Monkey) +5.04%
Nov-13-23 04:05PM	Eyenovia Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-06-23 08:00AM	Eyenovia to Report Third Quarter 2023 Results on Monday, November 13 (GlobeNewswire) -8.74%
Nov-02-23 07:00AM	Eyenovia Announces FDA Approval of Coastline International as Contract Manufacturer to Initiate Mydcombi Commercial Production (GlobeNewswire)
03:52PM	Loading…
Oct-30-23 03:52PM	Billionaire Marc Lasrys Top 10 Stock Picks (Insider Monkey) +6.48%
07:00AM	Eyenovia to Sponsor Course on Drug Delivery Innovation at IJCAHPO's 51st Annual Continuing Education (ACE) Program (GlobeNewswire)
Oct-09-23 07:00AM	Eyenovia to Present Data on Preservative-Free Microbial Integrity of the Optejet (GlobeNewswire)
Sep-21-23 08:00AM	Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare Conference (GlobeNewswire)
Sep-07-23 08:00AM	Eyenovia to Present at Upcoming H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-24-23 06:47PM	Eyenovia Announces $12 Million Registered Direct Offering (GlobeNewswire)
Aug-16-23 06:00AM	Eyenovia Acquires U.S. Commercial Rights to APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension, 0.05%) from Formosa Pharmaceuticals (GlobeNewswire) -6.44%
Aug-14-23 09:05AM	Eyenovia, Inc. (NASDAQ:EYEN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-11-23 06:08AM	Q2 2023 Eyenovia Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-10-23 04:05PM	Eyenovia Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-09-23 08:00AM	Eyenovia to Present at Upcoming H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference (GlobeNewswire)
Aug-07-23 08:00AM	Eyenovia to Report Second Quarter 2023 Results on Thursday, August 10 (GlobeNewswire)
Aug-03-23 08:00AM	Eyenovia Announces First Commercial Sale of Mydcombi (GlobeNewswire)
Jun-26-23 08:00AM	Eyenovia Announces Addition to Russell 2000® and Russell 3000® Indexes (GlobeNewswire) -6.75%
Jun-06-23 09:00AM	Eyenovia Expands Its US Manufacturing Capabilities (ACCESSWIRE)
Jun-01-23 08:00AM	Eyenovia Announces Presentation at the OCTANE Ophthalmology Tech Forum 2023 (GlobeNewswire) +9.15%
May-12-23 06:04AM	Q1 2023 Eyenovia Inc Earnings Call (Thomson Reuters StreetEvents) -15.20%
May-11-23 04:05PM	Eyenovia Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) -5.77%
May-08-23 04:39PM	Eyenovia Shares Dip Despite FDA Approving Its First Product (Benzinga)
08:17AM	UPDATE 2-US FDA approves Eyenovia's pupil-dilating spray (Reuters)
08:02AM	US FDA approves Eyenovia's pupil-dilating spray (Reuters)
08:00AM	Eyenovia Announces FDA Approval of Mydcombi, the First Ophthalmic Spray for Mydriasis, Which Also Leverages the Companys Proprietary Optejet® Device Platform (GlobeNewswire)
02:32AM	Weekly biotech pulse: Big catalysts on tap for Sarepta, Roche, Eyenovia, and more (Investing.com)
May-04-23 08:00AM	Eyenovia to Report First Quarter 2023 Results on Thursday, May 11 (GlobeNewswire) -12.87%
Apr-24-23 08:00AM	Eyenovia Announces Poster Presentation at ARVO 2023 (GlobeNewswire)
Apr-05-23 07:46PM	Eyenovia, Inc. (NASDAQ:EYEN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-30-23 04:05PM	Eyenovia Reports Fourth Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-23-23 08:00AM	Eyenovia to Report Fourth Quarter and Full-Year 2022 Results on Thursday, March 30 (GlobeNewswire) +9.16%
Feb-28-23 04:05PM	Eyenovia Announces Independent Director Stephen Benjamin to Step Down to Assume Role of Head of White Houses Office of Public Engagement (GlobeNewswire)
Feb-22-23 06:08AM	Eyenovia (NASDAQ:EYEN) shareholders have endured a 69% loss from investing in the stock five years ago (Simply Wall St.) +7.77%
Feb-15-23 09:51AM	Eyenovia Announces Development Collaboration Agreement with Formosa Pharmaceuticals (GlobeNewswire) +11.01%
Jan-12-23 12:47PM	Eyenovia's Optejet Shows Lower Proinflammatory Cytokines Levels, Chemokines Than Standard Drops (Benzinga) +17.02%
08:00AM	Eyenovia Reveals Positive Evidence That Optejet® Delivery Technology Decreased Inflammation From Preserved Glaucoma Solutions Compared to Drops (GlobeNewswire)
Dec-20-22 08:00AM	Eyenovia Announces Participation at the 2023 International Consumer Electronics Show (GlobeNewswire)
Dec-13-22 08:00AM	Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi for In-Office Pupil Dilation (GlobeNewswire) +7.51%
Dec-08-22 08:00AM	Eyenovia Announces Promotion of Bren Kern to Chief Operating Officer and Corporate Vice President (GlobeNewswire)
Nov-29-22 08:00AM	Eyenovia Announces $15 Million Credit Facility with Avenue Venture Debt Fund (GlobeNewswire) +6.49%
Nov-23-22 04:05PM	Eyenovia to Present at Upcoming BTIG Ophthalmology Day (GlobeNewswire) +5.59%
Nov-13-22 07:04AM	Eyenovia Third Quarter 2022 Earnings: US$0.21 loss per share (vs US$0.21 loss in 3Q 2021) (Simply Wall St.)
Nov-10-22 04:05PM	Eyenovia Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Nov-03-22 08:00AM	Eyenovia to Report Third Quarter 2022 Results on Thursday, November 10 (GlobeNewswire)
Oct-21-22 08:00AM	Eyenovia to Present at the American Academy of Optometrys Annual Meeting (GlobeNewswire)
Oct-20-22 08:00AM	Eyenovia Announces Positive Results from VISION-2 Phase 3 Study of MicroLine as a Potential On-Demand Treatment for Presbyopia (GlobeNewswire) -5.20%
Oct-05-22 02:50PM	HC Wainwright Initiates This Eye-Focused Stock With Almost 400% Upside (Benzinga) +13.02%
Sep-30-22 08:00AM	Eyenovia Announces Planned Retirement of Lead Independent Director Ken Lee, Jr. (GlobeNewswire)
Sep-07-22 08:00AM	Eyenovia to Present at Upcoming Healthcare Conferences (GlobeNewswire) +7.18%
Sep-06-22 08:00AM	Eyenovia to Participate in Multiple Medical Meetings in September (GlobeNewswire) +10.17%
Aug-10-22 04:05PM	Eyenovia Reports Second Quarter 2022 Financial Results (GlobeNewswire) +5.42%
Aug-04-22 08:00AM	Eyenovia to Report Second Quarter 2022 Results on Wednesday, August 10 (GlobeNewswire)
Jul-27-22 08:00AM	Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as Chief Executive Officer and Board Member (GlobeNewswire)
Jul-18-22 08:00AM	Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations (GlobeNewswire)
Jul-07-22 08:00AM	Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors (GlobeNewswire)
Jul-06-22 08:00AM	Eyenovia Strategic Partner Arctic Vision Enrolls First Patient in Phase III Clinical Trial of ARVN003 (MicroLine) for Presbyopia in China (GlobeNewswire)
Jun-29-22 08:53AM	Eyenovia (NASDAQ:EYEN) shareholders have endured a 65% loss from investing in the stock a year ago (Simply Wall St.)
Jun-09-22 10:09AM	UPDATE: Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders (GlobeNewswire) -5.19%
08:00AM	Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders (GlobeNewswire)
Jun-07-22 08:00AM	Eyenovia Announces Planned Chief Executive Officer Transition (GlobeNewswire)
May-15-22 08:06AM	Is Eyenovia (NASDAQ:EYEN) A Risky Investment? (Simply Wall St.)
May-12-22 04:05PM	Eyenovia Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-05-22 08:00AM	Eyenovia to Report First Quarter 2022 Results on Thursday, May 12 (GlobeNewswire)
Apr-20-22 08:00AM	Eyenovia CEO, CMO and Chairman Dr. Sean Ianchulev to Present at Eyecelerator @ American Society of Cataract and Refractive Surgery (ASCRS) 2022 (GlobeNewswire)
Apr-19-22 08:00AM	Eyenovia Announces Poster Presentation at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting (GlobeNewswire)
Apr-03-22 01:46PM	News Flash: One Analyst Just Made A Stunning Upgrade To Their Eyenovia, Inc. (NASDAQ:EYEN) Forecasts (Simply Wall St.)
Mar-31-22 01:17PM	Earnings Beat: Eyenovia, Inc. (NASDAQ:EYEN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts (Simply Wall St.)
Mar-28-22 04:05PM	Eyenovia Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Mar-21-22 08:00AM	Eyenovia to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28 (GlobeNewswire)
Mar-15-22 08:00AM	Eyenovia Announces Positive Study Results Demonstrating that its Optejet® Delivery Technology Reduces Conjunctival Cell Toxicity from Preserved Ophthalmic Solutions to a Level Comparable with Non-Preserved Solutions (GlobeNewswire)
Mar-04-22 09:07AM	Eyenovia Raises 15M Via Equity To Advance MydCombi Program (Benzinga)
07:00AM	Eyenovia Strengthens Balance Sheet with a $15 Million Institutional Capital Investment from Armistice Capital Master Fund Ltd. (GlobeNewswire)
Feb-13-22 06:29AM	Stuart Grant Just Bought A Sprinkling of Shares In Eyenovia, Inc. (NASDAQ:EYEN) (Simply Wall St.)

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grant Stuart M.	10% Owner	Mar 28 '24	Buy	0.98	100,000	98,000	5,430,715	Mar 28 03:50 PM
Grant Stuart M.	10% Owner	Mar 19 '24	Buy	1.23	50,000	61,500	5,330,715	Mar 20 05:44 PM
Grant Stuart M.	10% Owner	Mar 08 '24	Buy	1.58	10,717	16,911	5,280,715	Mar 11 08:11 AM
Rowe Michael M	Chief Executive Officer	Dec 04 '23	Buy	1.36	4,890	6,650	32,927	Dec 05 04:54 PM
Strahlman Ellen R	Director	Sep 29 '23	Buy	1.68	4,820	8,098	75,113	Oct 02 10:04 AM
Rowe Michael M	Chief Executive Officer	Sep 19 '23	Buy	1.66	1,400	2,324	28,037	Sep 19 05:17 PM
Rowe Michael M	Chief Executive Officer	Sep 15 '23	Buy	1.75	1,137	1,990	26,637	Sep 19 05:17 PM
Grant Stuart M.	10% Owner	Aug 17 '23	Buy	1.87	30,000	56,100	5,269,998	Aug 17 03:16 PM
Grant Stuart M.	10% Owner	Aug 16 '23	Buy	1.91	45,000	85,815	5,239,998	Aug 17 03:16 PM
GANDOLFO JOHN P	Chief Financial Officer	May 31 '23	Buy	2.79	2,000	5,580	8,000	May 31 06:31 PM
MATHER CHARLES E IV	Director	May 26 '23	Buy	2.49	3,000	7,470	77,544	May 30 10:13 AM
Kern Bren	Chief Operating Officer	May 26 '23	Buy	2.73	2,500	6,825	2,500	May 31 10:48 AM
Grant Stuart M.	10% Owner	May 25 '23	Buy	2.65	88,247	233,855	5,194,998	May 26 12:55 PM
Strahlman Ellen R	Director	May 23 '23	Buy	3.10	10,000	30,976	53,052	May 25 04:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EYEN

Eyenovia Inc

Upgrade your FINVIZ experience